IL6 and COVID-19: Based on their in vitro studies on the deactivation of IL-6 by HOCl at concentrations reported to develop in vivo, Robins et al. [54] suggest that exogenous HOCl and NCT might bring about beneficial effects in the treatment of COVID-19.